HallucinationsMethamphetaminePsychoses, Substance-InducedPsychotic DisordersAmphetamine-Related DisordersDelusionsCentral Nervous System StimulantsSchizophreniaSchizophrenic PsychologySubstance PParanoid DisordersSchizophrenia, ParanoidSleep ParalysisSubstance-Related DisordersPsychiatric Status Rating ScalesAffective Disorders, PsychoticAntipsychotic AgentsStreet DrugsDesigner DrugsAuditory Perceptual DisordersProdromal SymptomsAmphetamineSubstance Abuse DetectionLewy Body DiseaseSchizophrenia, ChildhoodEarly Medical InterventionParkinson DiseaseCognition DisordersNeuropsychological TestsBrainDelirium, Dementia, Amnestic, Cognitive DisordersN-Methyl-3,4-methylenedioxyamphetamineHallucinogensTemporal LobeDopamineSchizophrenic LanguageAmphetaminesMagnetic Resonance ImagingSelf AdministrationPseudoephedrineAlexia, PureBipolar Disorder3,4-MethylenedioxyamphetamineLewy BodiesPsilocybineDopamine Uptake InhibitorsOccipital LobeSchizotypal Personality DisorderDopamine Plasma Membrane Transport ProteinsStereotyped BehaviorMescalineLobelineDiagnostic and Statistical Manual of Mental DisordersCorpus StriatumGas Chromatography-Mass SpectrometryDose-Response Relationship, DrugTime FactorsAge of OnsetSubstance Abuse Treatment CentersMotor ActivityParapsychologyMental DisordersPerceptual DistortionFrontal LobeDopamine AgentsPsychomotor AgitationElectroencephalographyDreamsMarijuana AbuseNeurotoxicity SyndromesHistrionic Personality DisorderAnalysis of VarianceAntiparkinson AgentsVesicular Monoamine Transport ProteinsNarcolepsyBehavioral SymptomsPsychoses, AlcoholicDrug and Narcotic ControlCataplexyBehavior, AnimalCognitive TherapyPhenylcarbamatesRisk FactorsDrug-Seeking BehaviorSeverity of Illness Index